Difficulty: Medium
Average Score: 91%
Practice
Nicotinic acid
Correct answer
D
Rationale
Nicotinic acid, also known as niacin, is a medication commonly used to manage dyslipidemia in patients with cardiovascular disease. The correct answer is D) All of the above.
Explanation:
A) Nicotinic acid decreases the production of VLDL (Very Low-Density Lipoprotein) in the liver. VLDL is a type of lipoprotein that carries triglycerides, and inhibiting its production helps in reducing triglyceride levels.
B) Nicotinic acid decreases LDL (Low-Density Lipoprotein) levels by inhibiting the synthesis of VLDL, which is a precursor to LDL. Lowering LDL levels is crucial in reducing the risk of atherosclerosis and cardiovascular events.
C) Nicotinic acid increases HDL (High-Density Lipoprotein) levels by promoting the reverse cholesterol transport pathway, leading to the removal of excess cholesterol from peripheral tissues and its transport back to the liver for excretion. Higher HDL levels are associated with a reduced risk of cardiovascular disease.
Educational Context:
Understanding the effects of nicotinic acid on lipid levels is essential for healthcare professionals managing patients with dyslipidemia and cardiovascular disease. By knowing how nicotinic acid influences VLDL, LDL, and HDL levels, healthcare providers can make informed decisions about treatment options and tailor therapy to individual patient needs. This knowledge is crucial for optimizing patient outcomes and reducing the risk of cardiovascular events.
Explanation:
A) Nicotinic acid decreases the production of VLDL (Very Low-Density Lipoprotein) in the liver. VLDL is a type of lipoprotein that carries triglycerides, and inhibiting its production helps in reducing triglyceride levels.
B) Nicotinic acid decreases LDL (Low-Density Lipoprotein) levels by inhibiting the synthesis of VLDL, which is a precursor to LDL. Lowering LDL levels is crucial in reducing the risk of atherosclerosis and cardiovascular events.
C) Nicotinic acid increases HDL (High-Density Lipoprotein) levels by promoting the reverse cholesterol transport pathway, leading to the removal of excess cholesterol from peripheral tissues and its transport back to the liver for excretion. Higher HDL levels are associated with a reduced risk of cardiovascular disease.
Educational Context:
Understanding the effects of nicotinic acid on lipid levels is essential for healthcare professionals managing patients with dyslipidemia and cardiovascular disease. By knowing how nicotinic acid influences VLDL, LDL, and HDL levels, healthcare providers can make informed decisions about treatment options and tailor therapy to individual patient needs. This knowledge is crucial for optimizing patient outcomes and reducing the risk of cardiovascular events.